Literature DB >> 2658789

Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins.

L D Sabath1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2658789      PMCID： PMC172450          DOI： 10.1128/AAC.33.4.407

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  28 in total

1.  Nosocomial infection surveillance, 1984.

Authors:  T C Horan; J W White; W R Jarvis; T G Emori; D H Culver; V P Munn; C Thornsberry; D R Olson; J M Hughes
Journal:  MMWR CDC Surveill Summ       Date:  1986

2.  Pathogenesis and management of Staphylococcus epidermidis 'plastic' foreign body infections.

Authors:  G Peters; G Pulverer
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

Review 3.  Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.

Authors:  A W Karchmer
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

4.  Hip implant infection. Treatment with resection arthroplasty and late total hip arthroplasty.

Authors:  R H Fitzgerald; D R Jones
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

5.  Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery.

Authors:  T G Slama; S J Sklar; J Misinski; S W Fess
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.

Authors:  G L Woods; C C Knapp; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

7.  WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS.

Authors:  M H RICHMOND
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

8.  Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains.

Authors:  R F Frongillo; L Donati; G Federico; P Martino; M Moroni; L Ortona; M Palumbo; B M Pasticci; E Pizzigallo; G Privitera
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

9.  Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery.

Authors:  T R Beam; T A Raab; J A Spooner; S C Balderman; J Aldridge; J N Bahyana
Journal:  Am J Surg       Date:  1984-10-19       Impact factor: 2.565

10.  Comparative study of cefamandole versus cephalothin as antibiotic prophylaxis for open heart surgery.

Authors:  R Mészáros; M Windisch; C Koltai; L Lukács
Journal:  Cor Vasa       Date:  1986
View more
  8 in total

1.  Characterization of four beta-lactamases produced by Staphylococcus aureus.

Authors:  D J Zygmunt; C W Stratton; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits.

Authors:  P Chavanet; E Muggeo; A Waldner; S Dijoux; D Caillot; H Portier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 3.  [Antibiotic therapy: impact and resistance].

Authors:  S Weiler; N Corti
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-04       Impact factor: 0.840

4.  Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.

Authors:  Sandra Rincón; Jinnethe Reyes; Lina Paola Carvajal; Natalia Rojas; Fabián Cortés; Diana Panesso; Manuel Guzmán; Jeannete Zurita; Javier A Adachi; Barbara E Murray; Esteban C Nannini; Cesar A Arias
Journal:  J Antimicrob Chemother       Date:  2013-06-21       Impact factor: 5.790

Review 5.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.

Authors:  K-H Song; S-I Jung; S Lee; S Park; S M Kiem; S H Lee; Y G Kwak; Y K Kim; H-C Jang; Y-S Kim; H-I Kim; C J Kim; K-H Park; N J Kim; M-D Oh; H B Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-06       Impact factor: 3.267

7.  Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.

Authors:  E Yourassowsky; M P van der Linden; F Crokaert
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

8.  beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.

Authors:  M T Fields; B L Herndon; D M Bamberger
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.